|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| A61K 39/395 | |||
| C07K 16/30 | |||
| A61K 35/28 | |||
| A61K 38/17 |
| (11) | Number of the document | 3186395 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15835482.9 |
| Date of filing the European patent application | 2015-08-26 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/046976 |
| Date | 2015-08-26 |
| (87) | Number | WO 2016/033201 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 201462041989 P | 2014-08-26 | US |
| (72) |
SHIZURU, Judith, A., US
WEISKOPF, Kipp Andrew, US
RING, Aaron Michael, US
CHHABRA, Akanksha, US
SCHNORR, Peter, US
WEISSMAN Irving L., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING |
| ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING |